Retargeting of NK-92 Cells against High-Risk Rhabdomyosarcomas by Means of an ERBB2 (HER2/Neu)-Specific Chimeric Antigen Receptor
暂无分享,去创建一个
W. Wels | T. Klingebiel | H. Bönig | P. Bader | M. Merker | E. Rettinger | L. Pfeffermann | L. Moser | Leonie D. H. Gossel | C. Heim